| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/25/2003 | CN1112179C Sustained release and implantation type doxorubicin medicine and method for preparing same |
| 06/25/2003 | CN1112178C Sustained release and implantion type methotrexate medicine and method for preparing same |
| 06/25/2003 | CN1112177C Slowly releasing implanted medicines of penicillines and preparation thereof |
| 06/25/2003 | CN1112099C Non-spherical and non-platelet pyrithione salt |
| 06/24/2003 | US6583219 Three-dimensional, crosslinked interpenetrating polymer network |
| 06/24/2003 | US6583181 Antimicrobial quaternary ammonium compositions with reduced ocular irritation |
| 06/24/2003 | US6583174 Bi-cyclic compound dissolved in a glyceride; 7-((1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo(4,3,0)nonane -8-one-7-yl)heptanoic acid |
| 06/24/2003 | US6583164 Lyophilized imidazole-1-yl or 1,2,4-triazole-1-yl quaternized with a alklycarbonyloxy alkyl group eliminated in vivo; a saccharide; 4-acetoxymethyl-1-(3-(2-oxo-3-(4-(1H-tetrazol-yl) phenyl)-1-imidazolydinyl)butyl)-1H-1,2,4-triazolium chloride |
| 06/24/2003 | US6583160 Introducing nicotine into a user's bloodstream at a place where the the nicotine doses are carried to the brain before passing through the liver; pulsing dosage to mimic a puff of smoking; oral tablet; drug abuse |
| 06/24/2003 | US6583124 For controlled administration of pharmaceutically active agents to patients, wherein formulation is administered as liquids which thicken to form gels upon instillation into the eye |
| 06/24/2003 | US6582753 Hard caramel sweets and tablets |
| 06/24/2003 | US6582738 Process for preparing chewing gum containing a nutritional supplement |
| 06/24/2003 | US6582737 Pharmaceutical composition containing two active ingredients for smoking cessation |
| 06/24/2003 | US6582734 Antimicrobial composition useful for the treatment of bovine mastitis |
| 06/24/2003 | US6582729 By including water soluble polypeptide; administered by inhalation |
| 06/24/2003 | US6582728 On carrier of human serum albumin, carbohydrate, amino acid, polypeptide, buffer and/or salts; drug delivery to lungs |
| 06/24/2003 | US6582727 Two halves of the capsule will fuse together during the filling and cutting process under pressurization and high heat |
| 06/24/2003 | US6582724 Enhancing permeation of skin or mucosal tissue with topical hydroxide- releasing agent and lipophilic co-enhancer |
| 06/24/2003 | US6582721 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 06/24/2003 | US6582720 Medicinal compositions adhering to stomach/duodenum |
| 06/24/2003 | US6582718 Topical, ophthalmic cyclosporin A formulation having better distribution due to surfactant (polyoxyethylene fatty acid esters) causing less irritation to the eyes |
| 06/24/2003 | US6582717 Drug delivery composition and device |
| 06/24/2003 | US6582710 Products for topical applications comprising oil bodies |
| 06/24/2003 | US6582709 Composition for topical application for the treatment of skin disorders and skin diseases, comprising 1-6 wt. % Dead Sea Mud as an active ingredient. Said composition is for use in treating skin disorders and skin diseases such as psoriasis, |
| 06/24/2003 | US6582694 Method for preparing a viral aerosol |
| 06/24/2003 | US6582683 Dermal barrier composition |
| 06/24/2003 | US6582679 Hair wax products containing waxes, non-volatile oils and volatile hydrophobic materials |
| 06/24/2003 | US6582678 Carrier particles for use in dry powder inhalers |
| 06/24/2003 | US6582677 Pressurized aerosol composition comprising a liquefied hydrofluorocarbon propellant of formula CxHyFz where x is an integer from 1 to 3, y+z=2x+2, and y and z are both at least 1; from 0.01 to 15% w/w of a particulate medicament dispersed |
| 06/24/2003 | US6582627 Aqueous liquid, broad-spectrum, low free-formaldehyde synergistic preservative mixtures of an iodopropynyl compound and a formaldehyde donor |
| 06/24/2003 | US6582471 Composition and device for in vivo cartilage repair |
| 06/24/2003 | US6582418 Drug pump with reinforcing grooves |
| 06/24/2003 | US6582391 Extracorporeal device comprising insoluble collagen fibrils; embedded within matrix are cultured vertebrate cells which secrete polypeptides; shunting patient's blood through apparatus and back into patient; polypeptide mixes with blood |
| 06/24/2003 | US6581775 Method of external genital cleansing and prophylactic kit |
| 06/24/2003 | CA2221011C A coated sodium phosphate bowel cleanser |
| 06/24/2003 | CA2202679C Compacted medicament supply for generating inhalable medicament particles |
| 06/24/2003 | CA2130805C Use of mannose phosphates for the treatment of fibrotic disorders |
| 06/21/2003 | CA2414343A1 Film forming liquid composition |
| 06/21/2003 | CA2365806A1 Improved polymer-lipid delivery vehicles |
| 06/19/2003 | WO2003050281A2 Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity |
| 06/19/2003 | WO2003050280A1 Regulation of human fatty acid binding protein |
| 06/19/2003 | WO2003050198A1 Film structures and methods of making film structures |
| 06/19/2003 | WO2003050190A2 Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 06/19/2003 | WO2003050129A1 Use of phosphonate nucleotide analogue for treating hepatitis b virus infections |
| 06/19/2003 | WO2003049846A1 Method for preparing a multiple water/oil/water emulsion |
| 06/19/2003 | WO2003049805A1 Device for treating headache |
| 06/19/2003 | WO2003049804A2 Treatment of genitourinary tract disorders |
| 06/19/2003 | WO2003049786A2 Metering valve and pharmaceutical metered dose inhaler and methods thereof |
| 06/19/2003 | WO2003049783A2 Device and methods for harvesting tissue samples of known geometry |
| 06/19/2003 | WO2003049774A1 Transdermal transport of compounds |
| 06/19/2003 | WO2003049771A1 Edible capsules |
| 06/19/2003 | WO2003049726A1 Respiratory infection prevention and treatment with terpene-containing compositions |
| 06/19/2003 | WO2003049722A1 Process for making pre-formed objects |
| 06/19/2003 | WO2003049721A1 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 06/19/2003 | WO2003049719A2 Matrices for stabilizing and controlled release of problematic substances |
| 06/19/2003 | WO2003049718A1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 06/19/2003 | WO2003049717A2 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases |
| 06/19/2003 | WO2003049716A1 Stable topical formulation of clarithromycin |
| 06/19/2003 | WO2003049701A2 Methods and products useful in the formation and isolation of microparticles |
| 06/19/2003 | WO2003049689A2 Isoflavone composition for oral delivery |
| 06/19/2003 | WO2003049680A2 Compositions containing both sedative and non-sedative antihistamines |
| 06/19/2003 | WO2003049675A2 Treating muscle wasting with selective androgen receptor modulators |
| 06/19/2003 | WO2003049626A1 Method and apparatus for production of a skin graft and the graft produced thereby |
| 06/19/2003 | WO2003049593A2 Prevention of flap necrosis in plastic surgery |
| 06/19/2003 | WO2003049559A2 Method of producing a nicotine composition |
| 06/19/2003 | WO2003035002A3 Management of postoperative pain |
| 06/19/2003 | WO2003028767A3 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions and methods |
| 06/19/2003 | WO2003028657A3 Compositions for oral gene therapy and methods of using same |
| 06/19/2003 | WO2003011205A3 Encapsulation products for controlled or extended release |
| 06/19/2003 | WO2003007798A3 Ophthalmic use of 5 fluorourcil |
| 06/19/2003 | WO2003004096A3 Method and composition for prolonging the residence time of drugs in the gut |
| 06/19/2003 | WO2003003999A3 Delivery of a bioactive material |
| 06/19/2003 | WO2002047674A3 Use of intracellular calcium chelators (e.g bapta-am) to increase surfactant secretion in the lungs |
| 06/19/2003 | WO2002043660A3 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 06/19/2003 | WO2001091696A8 Use of biguanide derivatives for making a medicine having a wound healing effect |
| 06/19/2003 | US20030114837 Osmotic delivery system flow modulator apparatus and method |
| 06/19/2003 | US20030114836 Medication delivery system and monitor |
| 06/19/2003 | US20030114724 Polyubiquitin based hydrogel and uses thereof |
| 06/19/2003 | US20030114717 Aqueous D-mannitol solution as starting material, spray gas, pulverulent beta -mannitol and hot gas are combined, the resultant pulverulent product is precipitated into a fluidized bed, taken up, fluidized and transported further |
| 06/19/2003 | US20030114621 Comprises polymethyl methacrylate and/or polyethylhexyl acrylate formed by emulsion polymerization for balancing adhesion/cohesion |
| 06/19/2003 | US20030114537 Medical combinations comprising mometasone and salmeterol |
| 06/19/2003 | US20030114527 Administering an immediate release tablets containing 400 mg of 5-methyl-2-(2'- chloro-6'-fluoroanilino)phenylacetic acid or salts to a patient for the treatment of cyclooxygenase-2 mediated diseases |
| 06/19/2003 | US20030114497 Pharmaceutical compositions of amlodipine and atorvastatin |
| 06/19/2003 | US20030114494 Storage stability; bioavailability; core containing ndrug, enteric overcoating |
| 06/19/2003 | US20030114476 High potency dihydroergotamine compositions |
| 06/19/2003 | US20030114430 Aqueous solution; controlling flocculation; oxidation resistance |
| 06/19/2003 | US20030114428 Pharmaceutical compositions for the treatment of asthma |
| 06/19/2003 | US20030114426 Method for treating meibomian gland disease |
| 06/19/2003 | US20030114406 Dihydrazide derivatized hyaluronic acid crosslinked to a nucleic acid to transfect a cell, e.g. heart cell, to encoding a protein, e.g., endotheilial growth factor, to increase angiogenesis; antiischemic agents |
| 06/19/2003 | US20030114394 Vaginally administered anti-dysrhythmic agents for treating pelvic pain |
| 06/19/2003 | US20030114388 Auxiliary agents for ophthalmic operation |
| 06/19/2003 | US20030114384 Methods and compositions for treating lesions of the respiratory epithelium |
| 06/19/2003 | US20030114366 Uniform size, internal reservoirs that contain releaseable cytotoxic agents and communicate through pores filled or covered with release-delaying material and a layer of ligand molecules grafted to the face |
| 06/19/2003 | US20030114356 Method of treating irritable bowel syndrome |
| 06/19/2003 | US20030113845 Lyases; bactericides; gene knockout; animal husbandry |
| 06/19/2003 | US20030113704 Viricides; low chloride/hypotonic mixture for destroying blood parasites |
| 06/19/2003 | US20030113474 Methods using dry powder deposition apparatuses |
| 06/19/2003 | US20030113445 Powder material for electrostatic application to a substrate and electrostatic application of the powder material to a substrate |
| 06/19/2003 | US20030113389 Wherein dose of jojoba product provides simmondsin component in an amount greater than 0.05 gram/day |
| 06/19/2003 | US20030113387 Comprising Sasa albo-marginata (Bambooseae Sasa) extract; sulfur components |